RICHARD E LAVIGNE

Allopathic & Osteopathic Physicians|Internal Medicine ALBANY, NY NPI 1770575896

General Payments — all program years on this page

$11,153.95

  • Category: General Payments
  • Program years: PY2018–2023
  • Record count: 758
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $466.89 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $466.8920

By paying entity

Latest program year (PY2023) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $3,542.08240
2019 $2,367.32198
2020 $1,263.6083
2021 $1,713.53107
2022 $1,800.53110
2023 $466.8920

Records — PY2023 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1000241625 Bayer Healthcare Pharmaceuticals Inc. $13.55 01/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1000283881 Novo Nordisk Inc $23.11 03/08/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1000283887 Novo Nordisk Inc $24.18 02/25/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003365417 GlaxoSmithKline, LLC. $12.99 01/26/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003365421 GlaxoSmithKline, LLC. $13.88 02/16/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015344695 AstraZeneca Pharmaceuticals LP $120.35 02/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015631513 E.R. Squibb & Sons, L.L.C. $13.38 02/15/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1016010427 AstraZeneca Pharmaceuticals LP $33.59 01/05/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1020662609 Amgen Inc. $17.34 02/27/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1026514983 Exact Sciences Corporation $16.90 01/18/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1030869161 Sumitomo Pharma America, Inc. $15.02 01/09/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1030869165 Sumitomo Pharma America, Inc. $11.08 02/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1032055509 Lilly USA, LLC $18.42 01/31/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049445221 PFIZER INC. $14.64 03/31/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
986433815 Currax Pharmaceuticals LLC $14.72 11/16/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
992068681 Novartis Pharmaceuticals Corporation $21.24 01/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
992068685 Novartis Pharmaceuticals Corporation $16.22 03/08/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996665737 Boehringer Ingelheim Pharmaceuticals, Inc. $18.32 03/13/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996665745 Boehringer Ingelheim Pharmaceuticals, Inc. $16.30 02/08/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996665751 Boehringer Ingelheim Pharmaceuticals, Inc. $31.66 01/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.